Softwr

Research · head to head

Greenphire vs STARLIMS

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
STARLIMS logo

STARLIMS

Research

Laboratory information management from Abbott for regulated and public health labs

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • They diverge on capability: Greenphire covers ClinCard, STARLIMS covers Sample and specimen management.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and STARLIMS actually diverge.

Attributes where Greenphire and STARLIMS differ
AttributeGreenphireSTARLIMS
PlatformsWeb, iOS, AndroidWeb, Windows, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in STARLIMS

  • Sample and specimen management
  • Quality management
  • Instrument integration
  • Public health reporting
  • Regulatory compliance
  • Web and mobile access

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot STARLIMS
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot STARLIMS
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot STARLIMS
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot STARLIMS

STARLIMS

  • Public health laboratories handling surveillance and outbreak investigationnot Greenphire
  • Clinical laboratories needing regulated specimen tracking and reportingnot Greenphire
  • Food safety and environmental testing laboratoriesnot Greenphire
  • Multi-site laboratory networks standardising methods and specificationsnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

STARLIMS

  • Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
  • Pricing is quote-based with no public reference, making early budget setting difficult
  • The breadth across laboratory types means some verticals get less development attention than others
  • Interface modernisation has lagged behind newer cloud-native laboratory platforms
  • Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

STARLIMS

On request
  • STARLIMS$undefined/year
    • Sample management
    • Quality management
    • Instrument integration

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose STARLIMS if

  • You need sample and specimen management.
  • You work on Web, Windows, Cloud, On-premise.
  • You also want quality management.
STARLIMS review

Questions people ask

Is Greenphire or STARLIMS better?
Neither clearly leads. Greenphire starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or STARLIMS?
Greenphire starts at On request and STARLIMS at On request.
Does Greenphire or STARLIMS run on more platforms?
Greenphire runs on Web, iOS, Android. STARLIMS runs on Web, Windows, Cloud, On-premise.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what STARLIMS is typically brought in for.
What can Greenphire do that STARLIMS cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

STARLIMS: Who owns STARLIMS?

Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

STARLIMS: Where is it strongest?

Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

STARLIMS: What does it cost?

Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

STARLIMS: How does it compare to LabWare?

Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.

STARLIMS: What decides a successful implementation?

Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.

Share

Related pages

More on Greenphire

More on STARLIMS

Keep looking

Other head to heads